The Cancer Genomics Resource List 2014
作者： Mary M. Zutter , Kenneth J. Bloom , Liang Cheng , Ian S. Hagemann , Jill H. Kaufman
DOI: 10.5858/ARPA.2014-0330-CP
关键词:
摘要: Context.— Genomic sequencing for cancer is offered by commercial for-profit laboratories, independent laboratory networks, and laboratories in academic medical centers integrated health network...
allenpress.com
elsevier.com
archivesofpathology.org参考文章(157)
Julian Ananiev, Maya Gulubova, Georgi Tchernev, Mariana Penkova, Radostina Miteva, Alexander Julianov, Irena Manolova, Relation between transforming growth factor-β1 expression, its receptor and clinicopathological factors and survival in HER2-negative gastric cancers Wiener klinische Wochenschrift. ,vol. 123, pp. 668- 673 ,(2011) , 10.1007/S00508-011-0078-9
Matthew S. Karafin, Christopher T. Cummings, Baojin Fu, Christine A. Iacobuzio-Donahue, The developmental transcription factor Gata4 is overexpressed in pancreatic ductal adenocarcinoma. International Journal of Clinical and Experimental Pathology. ,vol. 3, pp. 47- 55 ,(2010)
Sai-Hong Ignatius Ou, Jeeyun Lee, Towards the goal of personalized medicine in gastric cancer--time to move beyond HER2 inhibition. Part I: Targeting receptor tyrosine kinase gene amplification. Discovery Medicine. ,vol. 15, pp. 333- ,(2013)
Sarah B. Fisher, Sameer H. Patel, Pelin Bagci, David A. Kooby, Bassel F. El-Rayes, Charles A. Staley, N. Volkan Adsay, Shishir K. Maithel, An analysis of human equilibrative nucleoside transporter‐1, ribonucleoside reductase subunit M1, ribonucleoside reductase subunit M2, and excision repair cross‐complementing gene‐1 expression in patients with resected pancreas adenocarcinoma Cancer. ,vol. 119, pp. 445- 453 ,(2013) , 10.1002/CNCR.27619
Amanda D. Bucheit, Erica Syklawer, John A. Jakob, Roland L. Bassett, Jonathan L. Curry, Jeffrey E. Gershenwald, Kevin B. Kim, Patrick Hwu, Alexander J. Lazar, Michael A. Davies, Clinical characteristics and outcomes with specific BRAF and NRAS mutations in patients with metastatic melanoma. Cancer. ,vol. 119, pp. 3821- 3829 ,(2013) , 10.1002/CNCR.28306
Helen J. Mackay, Elizabeth A. Eisenhauer, Suzanne Kamel-Reid, Ming Tsao, Blaise Clarke, Katherine Karakasis, Henrica M. J. Werner, Jone Trovik, Lars A. Akslen, Helga B. Salvesen, Dongsheng Tu, Amit M. Oza, Molecular determinants of outcome with mammalian target of rapamycin inhibition in endometrial cancer Cancer. ,vol. 120, pp. 603- 610 ,(2014) , 10.1002/CNCR.28414
Sara A Byron, Huaibin Chen, Andreas Wortmann, David Loch, Michael G Gartside, Farhad Dehkhoda, Steven P Blais, Thomas A Neubert, Moosa Mohammadi, Pamela M Pollock, The N550K/H mutations in FGFR2 confer differential resistance to PD173074, dovitinib, and ponatinib ATP-competitive inhibitors. Neoplasia. ,vol. 15, pp. 975- 988 ,(2013) , 10.1593/NEO.121106
Rebecca J Leeman‐Neill, Lindsey M Kelly, Pengyuan Liu, Alina V Brenner, Mark P Little, Tetiana I Bogdanova, Viktoria N Evdokimova, Maureen Hatch, Liudmyla Y Zurnadzy, Marina N Nikiforova, Ning J Yue, Miao Zhang, Kiyohiko Mabuchi, Mykola D Tronko, Yuri E Nikiforov, None, ETV6‐NTRK3 is a common chromosomal rearrangement in radiation‐associated thyroid cancer Cancer. ,vol. 120, pp. 799- 807 ,(2014) , 10.1002/CNCR.28484
Srishma Sridhar, Batool Al-Moallem, Hawra Kamal, Marta Terrile, Raymond L. Stallings, New Insights into the Genetics of Neuroblastoma Molecular Diagnosis & Therapy. ,vol. 17, pp. 63- 69 ,(2013) , 10.1007/S40291-013-0019-6
Nicholas Chiorazzi, Nicholas Chiorazzi, Implications of new prognostic markers in chronic lymphocytic leukemia Hematology. ,vol. 2012, pp. 76- 87 ,(2012) , 10.1182/ASHEDUCATION-2012.1.76